Presentations | Galecto

View our past and upcoming scientific conferences here.

October 7, 2024	Corporate Presentation
October 23, 2023	GALLANT-1: GB1211 Galectin-3 (Gal-3) inhibitor plus atezolizumab (atz) for first line treatment in patients (pts) with advanced/metastatic non-small cell lung cancer (NSCLC)
November 8, 2022	Galecto GULLIVER-2 Webcast Presentation
September 29, 2022	Galecto MYLOX-1 Call Presentation
November 8, 2021	Galecto Expert Perspectives: GB1211: A Potential Treatment for Non-Small Cell Lung Cancer
June 9, 2021	Galecto Expert Perspectives: Myelofibrosis Treatment Landscape Current and Potential Future Treatments Presentation